Not every special purpose acquisition company (SPAC) deal in medtech is an instant success.
On 28 September LumiraDx, the London-based point-of-care diagnostics manufacturer, floated on the NASDAQ following its merger with the SPAC called CA Healthcare Acquisition Corp
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?